No abstract

No abstract

No abstract

Prognostic methods represent a new methodology for system maintenance which offers significant time and cost savings. The paper offers a short overview of the available prognosis techniques and proposes the implementation of one model-based and one data-driven method. As a representative of the model-based methods the autoregressive moving average (ARMA) modeling approach is chosen. The estimated model parameters are further used for implementing the early change detector which is realized as a Neyman-Pearson hypothesis test. On the other hand, hidden Markov model (HMM) based prognosis illustrates the use of data-driven techniques. Using the cross-correlation input-output functions, HMM prognosis algorithm is proposed, as a suitable way of timely detection. Both techniques were implemented to detect performance changes of the water level sensor in a steam separator system in thermal power plants

The increasing prevalence of depression requires more effective therapy and the understanding of antidepressants’ mode of action. We carried out untargeted metabolomics of the prefrontal cortex of rats exposed to chronic social isolation (CSIS), a rat model of depression, and/or fluoxetine treatment using liquid chromatography–high resolution mass spectrometry. The behavioral phenotype was assessed by the forced swim test. To analyze the metabolomics data, we employed univariate and multivariate analysis and biomarker capacity assessment using the receiver operating characteristic (ROC) curve. We also identified the most predictive biomarkers using a support vector machine with linear kernel (SVM-LK). Upregulated myo-inositol following CSIS may represent a potential marker of depressive phenotype. Effective fluoxetine treatment reversed depressive-like behavior and increased sedoheptulose 7-phosphate, hypotaurine, and acetyl-L-carnitine contents, which were identified as marker candidates for fluoxetine efficacy. ROC analysis revealed 4 significant marker candidates for CSIS group discrimination, and 10 for fluoxetine efficacy. SVM-LK with accuracies of 61.50% or 93.30% identified a panel of 7 or 25 predictive metabolites for depressive-like behavior or fluoxetine effectiveness, respectively. Overall, metabolic fingerprints combined with the ROC curve and SVM-LK may represent a new approach to identifying marker candidates or predictive metabolites for ongoing disease or disease risk and treatment outcome.